Proteome Sciences plc (LON:PRM – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1.72 and traded as low as GBX 1.50. Proteome Sciences shares last traded at GBX 1.60, with a volume of 81,712 shares traded.
Proteome Sciences Trading Down 11.1%
The firm has a market cap of £5.61 million, a price-to-earnings ratio of -1.54 and a beta of 0.15. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46. The business has a 50 day moving average price of GBX 1.68 and a 200-day moving average price of GBX 1.72.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
